These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 752447)

  • 41. [THE TOPICAL USE OF CORTICOSTEROIDS IN DERMATOLOGY].
    POLANO MK
    Ned Tijdschr Geneeskd; 1965 Jan; 109():180-5. PubMed ID: 14301860
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
    Wiedersberg S; Naik A; Leopold CS; Guy RH
    Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydrocortisone (cortisol) concentration and penetration gradient.
    Kranz G; Schaefer H; Zesch A
    Acta Derm Venereol; 1977; 57(3):269-73. PubMed ID: 71836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assay of topical corticosteroids. Efficacy of suppression of experimental Rhus dermatitis in humans.
    Kaidbey KH; Kligman AM
    Arch Dermatol; 1976 Jun; 112(6):808-13. PubMed ID: 133636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of urea on the penetration kinetics of topically applied corticosteroids.
    Wohlrab W
    Acta Derm Venereol; 1984; 64(3):233-8. PubMed ID: 6204485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 47. Objective measurement of topically applied corticosteroids.
    Király K; Soós G
    Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of the efficiency of various externally used corticosteroids].
    Horácek J; Semrádová V
    Z Hautkr; 1974 Jul; 49(13):555-8. PubMed ID: 4423320
    [No Abstract]   [Full Text] [Related]  

  • 49. The same glucocorticoid in brand-name products. Does increasing the concentration result in greater topical biologic activity?
    Stoughton RB; Wullich K
    Arch Dermatol; 1989 Nov; 125(11):1509-11. PubMed ID: 2817915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bio-assay of corticosteroids for topical application.
    Spearman RI; Jarrett A
    Br J Dermatol; 1975 May; 92(5):581-4. PubMed ID: 1174471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus.
    Buajeeb W; Pobrurksa C; Kraivaphan P
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Jan; 89(1):42-5. PubMed ID: 10630940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The psoriasis bio-assay for topical corticosteroid activity.
    Dumas KJ; Scholtz JR
    Acta Derm Venereol; 1972; 52(1):43-8. PubMed ID: 4111105
    [No Abstract]   [Full Text] [Related]  

  • 53. Bioavailability of clobetasol propionate in different vehicles.
    Franz TJ; Lehman PA; Feldman SR; Spellman MC
    Skin Pharmacol Appl Skin Physiol; 2003; 16(4):212-6. PubMed ID: 12784060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation and identification of an oxidatively defluorinated metabolite of flunisolide in man.
    Tökés L; Cho D; Maddox ML; Chaplin MD; Chu NI
    Drug Metab Dispos; 1981; 9(5):485-6. PubMed ID: 6117452
    [No Abstract]   [Full Text] [Related]  

  • 55. Corticosteroid determination in skin preparations by a reaction rate method.
    Koupparis MA; Walczak KM; Malmstadt HV
    J Pharm Sci; 1979 Dec; 68(12):1479-82. PubMed ID: 529034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide.
    Malone T; Haleblian JK; Poulsen BJ; Burdick KH
    Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137
    [No Abstract]   [Full Text] [Related]  

  • 57. Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids.
    Kimura T; Doi K
    Toxicol Pathol; 1999; 27(5):528-35. PubMed ID: 10528632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Problems in selection of topical anti-inflammatory corticosteroids.
    Stewart WD; Runikis JO; Verma SC; Wallace S
    Can Med Assoc J; 1973 Jan; 108(1):33-8. PubMed ID: 4682636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procedures for the clinical investigation of a topical corticosteroid.
    Craps L; Ferner U
    Acta Derm Venereol Suppl (Stockh); 1973; 53():13-23. PubMed ID: 4585161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.